Synapse - Victor Reuter

Results (1228)

Non-urothelial carcinomas of the bladder

Review

Park, S.; Reuter, V. E.; Hansel, D. E.
Histopathology (2019)

Characterization of prostate cancer with MR spectroscopic imaging and diffusion-weighted imaging at 3 Tesla

Journal Article

Mazaheri, Y.; Shukla-Dave, A.; Goldman, D. A.; Moskowitz, C. S.; Takeda, T.; Reuter, V. E.; Akin, O.; Hricak, H.
Magnetic Resonance Imaging (2019)

Fulltext@MSK | Save

Adjuvant etoposide plus cisplatin (EP) for pathologic stage (PS) II nonseminomatous germ cell tumor (NSGCT)

Meeting Abstract

McHugh, D. J.; Funt, S.; Silber, D.; Knezevic, A.; Patil, S.; O'Donnell, D.; Tsai, S.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Etoposide and cisplatin (EP) for metastatic good-risk germ cell tumors (GCTs): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience in 944 patients (pts)

Meeting Abstract

Funt, S.; McHugh, D. J.; Tsai, S.; O'Donnell, D.; Knezevic, A.; Patil, S.; Silber, D.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Multicenter randomized phase 2 trial of paclitaxel, ifosfamide, and cisplatin (TIP) versus bleomycin, etoposide, and cisplatin (BEP) for first-line treatment of patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)

Meeting Abstract

Feldman, D. R.; Hu, J.; Srinivas, S.; Stadler, W. M.; Costello, B. A.; Appleman, L. J.; Milowsky, M. I.; Patil, S.; Bromberg, M.; Nolan, P.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Microsatellite instability in prostate cancer and response to immune checkpoint blockade

Meeting Abstract

Abida, W.; Cheng, M. L.; Armenia, J.; Middha, S.; Autio, K. A.; Rathkopf, D. E.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; Carbone, E.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Association of preoperative neutrophil-to-lymphocyte ratio with immune populations in the tumor microenvironment of patients with clear cell renal cell carcinoma

Meeting Abstract

Sanchez, A.; Liu, M.; Nixon, B.; Ghanaat, M.; DiNatale, R.; Blum, K. A.; Russo, P.; Reuter, V. E.; Li, M.; Hakimi, A. A.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Everolimus (E) plus bevacizumab (B) is effective first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) with papillary features (PF): Results from a phase II trial

Meeting Abstract

Feldman, D. R.; Lee, C. H.; Molina, A. M.; Knezevic, A.; Chen, Y.; Chaim, J.; Coskey, D. T.; Ged, Y.; Tickoo, S.; Reuter, V. E.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Adjuvant etoposide plus cisplatin (EP) for pathologic stage (PS) II nonseminomatous germ cell tumor (NSGCT)

Meeting Abstract

McHugh, D. J.; Funt, S.; Silber, D.; Knezevic, A.; Patil, S.; O'Donnell, D.; Tsai, S.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Granular cell tumor of the bladder: A report of six cases

Journal Article

Sun, Y.; Reuter, V. E.; Magi-Galluzzi, C.; Sankin, A.; Epstein, J. I.
Urology (2018)

Fulltext@MSK | Save